Search Results - "Marten, Claire"

Metronidazole and cefazolin vs cefazolin alone for surgical site infection prophylaxis in gynecologic surgery at a comprehensive cancer center by Knisely, Anne, Iniesta, Maria D., Marten, Claire A., Chisholm, Gary, Schmeler, Kathleen M., Taylor, Jolyn S.

“…Surgical site infection is one of the most common complications of gynecologic cancer surgery. Current guidelines recommend the administration of cefazolin…”
Get full text

Tisotumab vedotin extravasation injury in a patient with recurrent cervical cancer by Son, Ji, Cain, Katherine E., Marten, Claire A., Dwyer, Kaitlin W, Sims, Travis T., Taylor, Jolyn S.

“…•Infusion site extravasation injury is a rare but serious adverse event of tisotumab vedotin.•Central venous access device should be considered in patients…”
Get full text

Choosing Wisely: Decreasing the incidence of perioperative blood transfusions in gynecologic oncology by Prescott, Lauren S., Taylor, Jolyn S., Enbaya, Ahmed, Marten, Claire A., Myers, Keith N., Meyer, Larissa A., Ramirez, Pedro T., Levenback, Charles F., Bodurka, Diane C., Schmeler, Kathleen M.

“…To evaluate the efficacy and economic impact of a transfusion reduction initiative for patients undergoing gynecologic surgery. We conducted a prospective…”
Get full text

The DISINFECT Initiative: Decreasing the Incidence of Surgical INFECTions in Gynecologic Oncology by Taylor, Jolyn S., Marten, Claire A., Munsell, Mark F., Sun, Charlotte C., Potts, Kimberly A., Burzawa, Jennifer K., Nick, Alpa M., Meyer, Larissa A., Myers, Keith, Bodurka, Diane C., Aloia, Thomas A., Levenback, Charles F., Lairson, David R., Schmeler, Kathleen M.

“…Background Surgical site infections (SSIs) lead to increased patient morbidity and healthcare costs. Our objective was to decrease the SSI rate following…”
Get full text

Update of Targeted Therapy-Induced Hypertension: Basics for Non-Oncology Providers by Escalante, Carmen P, Lu, Maggie, Marten, Claire A

“…Over the past several years, cancer treatments have expanded from usual chemotherapy standards with introduction of newer targeted therapies. As with…”
Get more information

A new standard for surgical site infection prevention in gynecologic cancer: Metronidazole plus cefazolin better than cefazolin alone by Knisely, Anne, Iniesta-Donate, Maria, Cain, Katherine, Marten, Claire, Chisholm, Gary, Schmeler, Kathleen, Taylor, Jolyn

Get full text

Comparison of out-of-pocket cost between apixaban and enoxaparin for extended-duration venous thromboembolism prophylaxis in gynecologic oncology patients by Cain, Katherine, Harrison, Ross, Marten, Claire, Fleming, Nicole, Taylor, Jolyn

“…To compare out-of-pocket cost between apixaban and enoxaparin for prevention of postoperative venous thromboembolism (VTE) in gynecologic oncology patients…”
Get full text

Setting the standard for postoperative venous thromboembolism prophylaxis among gynecologic cancer patients: Apixaban showed similar outcomes with lower cost compared to enoxaparin by Knisely, Anne, Batman, Samantha, Iniesta-Donate, Maria, Meyer, Larissa, Soliman, Pamela, Cain, Katherine, Marten, Claire, Chisholm, Gary, Schmeler, Kathleen, Taylor, Jolyn, Fleming, Nicole

Get full text

What Is the Real Rate of Surgical Site Infection? by Taylor, Jolyn S, Marten, Claire A, Potts, Kimberly A, Cloutier, Lynn M, Cain, Katherine E, Fenton, Shauna L, Tatum, Tara N, James, Deepthi A, Myers, Keith N, Hubbs, Cheryl A, Burzawa, Jennifer K, Vachhani, Shital, Nick, Alpa M, Meyer, Larissa A, Graviss, Linda S, Ware, Kathy M, Park, Anne K, Aloia, Thomas A, Bodurka, Diane C, Levenback, Charles F, Schmeler, Kathleen M

“…Surgical site infections (SSIs) are associated with patient morbidity and increased health care costs. Although several national organizations including the…”
Get full text

Efficacy, safety, and feasibility of Apixaban for postoperative venous thromboembolism prophylaxis following open gynecologic cancer surgery at a comprehensive cancer center by Knisely, Anne, Iniesta, Maria D., Batman, Samantha, Meyer, Larissa A., Soliman, Pamela T., Cain, Katherine E., Marten, Claire, Chisholm, Gary, Schmeler, Kathleen M., Taylor, Jolyn S., Fleming, Nicole D.

“…To evaluate safety, efficacy, and feasibility of apixaban for postoperative venous thromboembolism (VTE) prophylaxis following open gynecologic cancer surgery…”
Get full text

Metronidazole and cefazolin versus cefazolin alone for surgical site infection prophylaxis in gynecologic surgery at a comprehensive cancer center by Knisely, Anne, Iniesta, Maria D, Marten, Claire A, Chisholm, Gary, Schmeler, Kathleen M, Taylor, Jolyn S

“…Surgical site infection (SSI) is one of the most common complications of gynecologic cancer surgery. Current guidelines recommend the administration of…”
Get full text

2030. Risk Factors for Recurrent Percutaneous Nephrostomy Tube Infections in Patients with Gynecological Malignancies by Szvalb, Ariel D, Marten, Claire A, Cain, Katherine E, Taylor, Jolyn, Huang, Steven Y, Viola, George M

“…Abstract Background Percutaneous nephrostomy tube infections (PCNIs) are complex, affect quality of life, necessitate implant exchanges, and increase health…”
Get full text

An initiative to improve mortality index in gynecologic oncology by Taylor, Jolyn Sharpe, Miller, Jennifer F., Ballard, Edith K., Blanco, Tricia K., Brown, Karen L., Byrd, Corrine C., Holloway, Anita, Smith, Arletta, Park, Anne, Cain, Katherine, Marten, Claire, Finch, Roshonda, Nguyen, Van, Fleming, Donna, Levenback, Charles F., Lu, Karen H., Schmeler, Kathleen M.

“…Abstract only 256 Background: The mortality index (MI) is a quality metric that measures the ratio of actual mortality to expected mortality among inpatients…”
Get full text

What is the real rate of surgical-site infection? by Taylor, Jolyn Sharpe, Marten, Claire, Potts, Kimberly, Cloutier, Lynn, Cain, Katherine, Fenton, Shauna, Tatum, Tara, James, Deepthi, Hubbs, Cheryl, Burzawa, Jennifer, Vachhani, Shital, Nick, Alpa Manchandia, Meyer, Larissa, Graviss, Linda, Ware, Kathy, Park, Anne, Aloia, Thomas A., Bodurka, Diane C., Levenback, Charles F., Schmeler, Kathleen M.

“…Abstract only 171 Background: Surgical site infections (SSI) are associated with patient morbidity and increased healthcare costs. Although several national…”
Get full text